Trial · NCT02172573
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in total score of the Unified Parkinson's Disease Rating Scale (UPDRS) Part II (Activities of Daily Living) | Baseline and week 12 | |
| Primary | Change from baseline in total score of UPDRS Part III (Motor Examination) | Baseline and week 12 | |
| Secondary | Changes from baseline in sores of individual items on UPDRS Part II | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Changes from baseline in scores of individual items on UPDRS Part III | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in area under the curve (AUC) in the UPDRS Part II score | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in area under the curve (AUC) in the UPDRS Part III score | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part I (mentation, behaviour and mood) | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part IV (complications of therapy) | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part I-III | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part I-IV | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in Modified Hoehn & Yahr stage | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Clinical global impression of efficacy | week 12 | |
| Secondary | Number of patients with adverse events | up to 16 weeks | |
| Secondary | Number of patients with clinically significant changes in vital signs (blood pressure, pulse rate) | up to 12 weeks | |
| Secondary | Number of patients with abnormal changes in laboratory parameters | up to 12 weeks | |
| Secondary | Number of patients with abnormal changes in 12-lead electrocardiogram (ECG) | up to 12 weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02172573/registered